World Journal of Nuclear Medicine

ORIGINAL ARTICLE
Year
: 2020  |  Volume : 19  |  Issue : 2  |  Page : 99--105

Comparison of68Ga-DOTA-NaI3-Octreotide/tyr3-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome


Virendra A Patil1, Manjunath R Goroshi1, Hina Shah2, Gaurav Malhotra3, Priya Hira4, Vijaya Sarathi5, Vikram R Lele2, Swati Jadhav1, Anurag Lila1, Tushar R Bandgar1, Nalini S Shah1 
1 Department of Endocrinology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India
2 Department of Nuclear Medicine and Positron Emission Tomography/Computed Tomography, Jaslok Hospital and Research Centre, Mumbai, Maharashtra, India
3 Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre, Mumbai, Maharashtra, India
4 Department of Radiology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India
5 Department of Endocrinology, Narayana Medical College, Nellore, Andhra Pradesh, India

Correspondence Address:
Dr. Swati Jadhav
Department of Endocrinology, Seth GS Medical College and KEM Hospital, Parel, Mumbai - 400 012, Maharashtra
India

The optimum imaging modality for the screening of multiple endocrine neoplasia type 1 (MEN1)-associated tumors is not well established. Here, we compare the performance of contrast-enhanced CT (CECT) versus68Ga DOTA-NOC/TATE PET/CT in MEN1 patients. The retrospective case record study is conducted at a tertiary health-care center. Thirty-four patients, who have undergone both CECT and68Ga DOTA-NOC/TATE PET, were included in the analysis. CECT had higher per-lesion sensitivity than68Ga DOTA-NOC/TATE PET/CT for the detection of parathyroid lesions, (82.6% vs. 24.6%, P < 0.001).68Ga DOTA-NOC/TATE PET/CT had higher per-lesion sensitivity than CECT for the detection of metastases (85% vs. 47.5%, P < 0.001) and gastrinomas (90% vs. 10%, P = 0.003). When combined use of the two imaging modalities is compared to CECT alone (63.7% vs. 93.1%, P = 0.00012) and68Ga-DOTA-NOC/TATE PET/CT alone (74.1% vs. 93.1%, P = 0.0057), it provided significantly higher per-lesion sensitivity for the detection of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).68Ga-DOTA-NOC/TATE PET was more sensitive for the detection of gastrinomas and metastases than CECT, whereas it was less sensitive for the detection of parathyroid lesions than CECT. The combined use of both the imaging modalities significantly increases the sensitivity for detection of GEP-NETs.


How to cite this article:
Patil VA, Goroshi MR, Shah H, Malhotra G, Hira P, Sarathi V, Lele VR, Jadhav S, Lila A, Bandgar TR, Shah NS. Comparison of68Ga-DOTA-NaI3-Octreotide/tyr3-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome.World J Nucl Med 2020;19:99-105


How to cite this URL:
Patil VA, Goroshi MR, Shah H, Malhotra G, Hira P, Sarathi V, Lele VR, Jadhav S, Lila A, Bandgar TR, Shah NS. Comparison of68Ga-DOTA-NaI3-Octreotide/tyr3-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome. World J Nucl Med [serial online] 2020 [cited 2020 Jul 16 ];19:99-105
Available from: http://www.wjnm.org/article.asp?issn=1450-1147;year=2020;volume=19;issue=2;spage=99;epage=105;aulast=Patil;type=0